{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:14:24Z","timestamp":1788779664134,"version":"build-2803163510"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The skin, covering our entire body as its largest organ, manifests enormous complexities and a profound interplay of systemic and local responses. In this heterogeneous domain, B cells were considered strangers. Yet, recent studies have highlighted their existence in the skin and their distinct role in modulating cutaneous immunity across various immune contexts. Accumulating evidence is progressively shedding light on the significance of B cells in maintaining skin health and in skin disorders. Herein, we integrate current insights on the systemic and local contributions of B cells in three prevalent inflammatory skin conditions: Pemphigus Vulgaris (PV), Systemic Lupus Erythematosus (SLE), and Atopic Dermatitis (AD), underscoring the previously underappreciated importance of B cells within skin immunity. Moreover, we address the potential adverse effects of current treatments used for skin diseases, emphasizing their unintentional consequences on B cells. These comprehensive approaches may pave the way for innovative therapeutic strategies that effectively address the intricate nature of skin disorders.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1328785","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:00:01Z","timestamp":1707973201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["From neglect to spotlight: the underappreciated role of B cells in cutaneous inflammatory diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Eun-Gang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","article-title":"T cells and the skin: from protective immunity to inflammatory skin disorders","volume":"19","author":"Ho","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri3683","article-title":"The origins and functions of dendritic cells and macrophages in the skin","volume":"14","author":"Malissen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of cla+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.247","article-title":"Skin-resident T cells: the ups and downs of on site immunity","volume":"130","author":"Clark","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.12.006","article-title":"Revisiting the role of B cells in skin immune surveillance","volume":"36","author":"Egbuniwe","year":"2015","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801211","article-title":"Skin-associated B cells in health and inflammation","volume":"202","author":"Debes","year":"2019","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.21037\/atm-20-5185","article-title":"Human cutaneous B cells: what do we really know","volume":"9","author":"Lerman","year":"2021","journal-title":"Ann Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.3390\/cells9122627","article-title":"Skin-associated B cells in the pathogenesis of cutaneous autoimmune diseases-implications for therapeutic approaches","volume":"9","author":"Fetter","year":"2020","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1525-1578(10)60609-5","article-title":"Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas","volume":"2","author":"Nihal","year":"2000","journal-title":"J Mol Diagn"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102639","article-title":"The skin, a novel niche for recirculating B cells","volume":"188","author":"Geherin","year":"2012","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.vetimm.2013.01.004","article-title":"Afferent lymphatic cannulation as a model system to study innate immune responses to infection and vaccination","volume":"158","author":"Neeland","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403246","article-title":"Il-10+ Innate-like B cells are part of the skin immune system and require alpha4beta1 integrin to migrate between the peritoneum and inflamed skin","volume":"196","author":"Geherin","year":"2016","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12470172","article-title":"The skin immune system (Sis): distribution and immunophenotype of lymphocyte subpopulations in normal human skin","volume":"88","author":"Bos","year":"1987","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081x(95)00087-v","article-title":"Immune cell traffic from blood through the normal human skin to lymphatics","volume":"13","author":"Olszewski","year":"1995","journal-title":"Clin Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7779","article-title":"Tlr agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses","volume":"178","author":"Genestier","year":"2007","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061041","article-title":"Regulation of B1 cell migration by signals through toll-like receptors","volume":"203","author":"Ha","year":"2006","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47015","article-title":"B cell receptor and toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota","volume":"8","author":"Kreuk","year":"2019","journal-title":"Elife"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/srep29736","article-title":"Igg subclass switching and clonal expansion in cutaneous melanoma and normal skin","volume":"6","author":"Saul","year":"2016","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12560807","article-title":"Identification of secretory immunoglobulin a in human sweat and sweat glands","volume":"90","author":"Okada","year":"1988","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep13070402","article-title":"Immunohistochemical demonstration of immunoglobulin a in human sebaceous and sweat glands","volume":"92","author":"Metze","year":"1989","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12469908","article-title":"Immunoglobulins coat microorganisms of skin surface: A comparative immunohistochemical and ultrastructural study of cutaneous and oral microbial symbionts","volume":"96","author":"Metze","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.05.009","article-title":"Igm plasma cells reside in healthy skin and accumulate with chronic inflammation","volume":"139","author":"Wilson","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1038\/s41467-023-42625-4","article-title":"Tissue-resident B cells orchestrate macrophage polarisation and function","volume":"14","author":"Suchanek","year":"2023","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225152","article-title":"Compartmentalized control of skin immunity by resident commensals","volume":"337","author":"Naik","year":"2012","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080355","article-title":"Cd19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced tlr4 signaling","volume":"175","author":"Iwata","year":"2009","journal-title":"Am J Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800003105","article-title":"Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia","volume":"105","author":"Joo","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"Onodera","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142284","article-title":"Distinct germinal center selection at local sites shapes memory B cell response to viral escape","volume":"212","author":"Adachi","year":"2015","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral iga","volume":"6","author":"Oh","year":"2021","journal-title":"Sci Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953088","article-title":"Resident memory B cells in barrier tissues","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1285-1","article-title":"Migrant memory B cells secrete luminal antibody in the vagina","volume":"571","author":"Oh","year":"2019","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12650","article-title":"Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance","volume":"283","author":"Gebhardt","year":"2018","journal-title":"Immunol Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.618897","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2020","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.6.1461","article-title":"The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1","volume":"174","author":"Berg","year":"1991","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499816","article-title":"Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin","volume":"98","author":"Groves","year":"1992","journal-title":"J Invest Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/cimm.1999.1552","article-title":"Cutaneous lymphocyte antigen is expressed on memory\/effector B cells in the peripheral blood and monocytoid B cells in the lymphoid tissues","volume":"197","author":"Yoshino","year":"1999","journal-title":"Cell Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.68.6.807","article-title":"Expression of alpha4beta7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites","volume":"68","author":"Rott","year":"2000","journal-title":"J Leukoc Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02843.x","article-title":"Differential expression of chemokine receptors on human iga+ and igg+ B cells","volume":"141","author":"Johansson","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxf054","article-title":"Chemotaxis of human tonsil B lymphocytes to cc chemokine receptor (Ccr) 1, ccr2 and ccr4 ligands is restricted to non-germinal center cells","volume":"14","author":"Corcione","year":"2002","journal-title":"Int Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B44","article-title":"Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption","volume":"145","author":"Teraki","year":"1994","journal-title":"Am J Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335465","article-title":"Epidermal T cells: their functional role and disease relevance for dermatologists","volume":"109","author":"Shiohara","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(03)01624-5","article-title":"Ifn-gamma-producing effector cd8+ T cells and il-10-producing regulatory cd4+ T cells in fixed drug eruption","volume":"112","author":"Teraki","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaci.2015.08.027","article-title":"Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.181.1.1","article-title":"Autoantibodies against adhesion molecules and structures in blistering skin diseases","volume":"181","author":"Stanley","year":"1995","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.03.1661","article-title":"Desmoglein-specific B-cell-targeted single-cell analysis revealing unique gene regulation in patients with pemphigus","volume":"143","author":"Egami","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01375","article-title":"Identification of autoreactive B cell subpopulations in peripheral blood of autoimmune patients with pemphigus vulgaris","volume":"10","author":"Pollmann","year":"2019","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.32607\/actanaturae.11890","article-title":"B cell profiling in patients with pemphigus vulgaris","volume":"15","author":"Abrikosova","year":"2023","journal-title":"Acta Naturae"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jid.2019.07.717","article-title":"Autoreactive B cell differentiation in diffuse ectopic lymphoid-like structures of inflamed pemphigus lesions","volume":"140","author":"Zhou","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2006.01819.x","article-title":"Autoantibody determination in the diagnosis of systemic lupus erythematosus","volume":"64","author":"Kurien","year":"2006","journal-title":"Scand J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230411","article-title":"The specificity and clinical usefulness of the lupus band test","volume":"23","author":"Harrist","year":"1980","journal-title":"Arthritis Rheum"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.023","article-title":"Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease","volume":"1050","author":"Lyons","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00713-9","article-title":"From blood to tissue: take a deeper look at B cells in lupus","volume":"18","author":"Fu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1241474","article-title":"Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis","volume":"14","author":"Wing","year":"2023","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/00313020802320739","article-title":"Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis","volume":"40","author":"Hussein","year":"2008","journal-title":"Pathology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/925805","article-title":"Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin","volume":"2014","author":"Thorpe","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"B65","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.0303-6987.2005.00351.x","article-title":"Lupus erythematosus panniculitis (Lupus profundus): clinical, histopathological, and molecular analysis of nine cases","volume":"32","author":"Massone","year":"2005","journal-title":"J Cutan Pathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14498","article-title":"Analysis of possible structures of inducible skin-associated lymphoid tissue in lupus erythematosus profundus","volume":"45","author":"Kogame","year":"2018","journal-title":"J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00640","article-title":"In silico analyses of skin and peripheral blood transcriptional data in cutaneous lupus reveals ccr2-a novel potential therapeutic target","volume":"10","author":"Dey-Rao","year":"2019","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13419","article-title":"High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus","volume":"27","author":"Wenzel","year":"2018","journal-title":"Exp Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \u201cAutoreactivity\u201d Play a role in atopic dermatitis","volume":"129","author":"Tang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40629-015-0037-5","article-title":"Autoallergy in atopic dermatitis","volume":"24","author":"Hradetzky","year":"2015","journal-title":"Allergo J Int"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102634","article-title":"Autoreactive T cells and their role in atopic dermatitis","volume":"120","author":"De Bruyn Carlier","year":"2021","journal-title":"J Autoimmun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.alit.2021.07.003","article-title":"Subtypes of atopic dermatitis: from phenotype to endotype","volume":"71","author":"Tokura","year":"2022","journal-title":"Allergol Int"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.02.001","article-title":"Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis","volume":"150","author":"Mobus","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.02.042","article-title":"Cd19 expression in B cells regulates atopic dermatitis in a mouse model","volume":"182","author":"Yanaba","year":"2013","journal-title":"Am J Pathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.immuni.2021.08.028","article-title":"Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation","volume":"54","author":"Duan","year":"2021","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005083","article-title":"Plasmablasts derive from cd23- activated B cells after the extinction of il-4\/stat6 signaling and irf4 induction","volume":"137","author":"Pignarre","year":"2021","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744573","article-title":"Committed human cd23-negative light-zone germinal center B cells delineate transcriptional program supporting plasma cell differentiation","volume":"12","author":"Santamaria","year":"2021","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1993.1015","article-title":"Interleukin-4 signals regulating cd23 gene expression in human B cells: protein kinase C-independent signaling pathways","volume":"146","author":"Lee","year":"1993","journal-title":"Cell Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.10.009","article-title":"Regulation of immunity and autoimmunity by B cells","volume":"22","author":"Mauri","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21438","article-title":"Helminth infections associated with multiple sclerosis induce regulatory B cells","volume":"64","author":"Correale","year":"2008","journal-title":"Ann Neurol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"Cd19(+)Cd24(Hi)Cd38(Hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare il-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.05.015","article-title":"Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy","volume":"63","author":"Ponte","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000756","article-title":"Autoimmune sequelae following rituximab therapy: A review of the literature and potential immunologic mechanisms","volume":"24","author":"Kersh","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080929","article-title":"Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-hodgkin lymphoma","volume":"67","author":"Mielke","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cia2.12059","article-title":"Il-10-producing regulatory B cells in skin diseases","volume":"2","author":"Suga","year":"2019","journal-title":"J Cutan Immunol All"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088441","article-title":"T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13295","article-title":"Increase of interleukin-10-producing B cells associated with long-term remission after I.V. Immunoglobulin treatment for pemphigus","volume":"43","author":"Kabuto","year":"2016","journal-title":"J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15113","article-title":"Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid","volume":"176","author":"Kabuto","year":"2017","journal-title":"Br J Dermatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13192","article-title":"Impaired function of cd19(+) cd24(Hi) cd38(Hi) regulatory B cells in patients with pemphigus","volume":"172","author":"Zhu","year":"2015","journal-title":"Br J Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132173","article-title":"Impaired function of cd5+Cd19+Cd1dhi B10 cells on ige secretion in an atopic dermatitis-like mouse model","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.08.016","article-title":"Il-10-producing regulatory B cells are decreased in patients with atopic dermatitis","volume":"139","author":"Yoshihara","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785549","article-title":"Crosstalk between circulating follicular T helper cells and regulatory B cells in children with extrinsic atopic dermatitis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aas9944","article-title":"Baff inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci Adv"},{"key":"B101","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040119","article-title":"The innate mononuclear phagocyte network depletes B lymphocytes through fc receptor-dependent mechanisms during anti-cd20 antibody immunotherapy","volume":"199","author":"Uchida","year":"2004","journal-title":"J Exp Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.3674","article-title":"Intralesional rituximab in the treatment of refractory oral pemphigus vulgaris","volume":"151","author":"Vinay","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.031","article-title":"Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory pemphigus vulgaris lesions: A randomized clinical trial","volume":"73","author":"Iraji","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase iii trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/art.39085","article-title":"Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus","volume":"67","author":"Vital","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3793","article-title":"Assessment of response to B-cell depletion using rituximab in cutaneous lupus erythematosus","volume":"154","author":"Quelhas da Costa","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.11.016","article-title":"Anti-cd20 (Rituximab) treatment improves atopic eczema","volume":"121","author":"Simon","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nature13803","article-title":"T-B-cell entanglement and icosl-driven feed-forward regulation of germinal centre reaction","volume":"517","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.11.007","article-title":"Differential expression of baff and its receptors in discoid lupus erythematosus patients","volume":"73","author":"Chong","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316682097","article-title":"Belimumab for the treatment of recalcitrant cutaneous lupus","volume":"26","author":"Vashisht","year":"2017","journal-title":"Lupus"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0235-5","article-title":"New therapies for systemic lupus erythematosus - past imperfect, future tense","volume":"15","author":"Murphy","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary sjogren\u2019s syndrome with ianalumab (Vay736) targeting B cells by baff receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"Dorner","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16679","article-title":"Targeting therapy in pemphigus: where are we now and where are we going","volume":"9","author":"Abulikemu","year":"2023","journal-title":"Heliyon"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.708071","article-title":"Bruton tyrosine kinase inhibition and its role as an emerging treatment in pemphigus","volume":"8","author":"Patsatsi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12615","article-title":"Successful use of bruton\u2019s kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia","volume":"58","author":"Lee","year":"2017","journal-title":"Australas J Dermatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13351","article-title":"A phase I trial of prn1008, a novel reversible covalent inhibitor of bruton\u2019s tyrosine kinase, in healthy volunteers","volume":"83","author":"Smith","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0081-9","article-title":"Targeting co-stimulatory molecules in autoimmune disease","volume":"19","author":"Edner","year":"2020","journal-title":"Nat Rev Drug Discovery"},{"key":"B125","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/cells8080927","article-title":"Targeting the cd40-cd154 signaling pathway for treatment of autoimmune arthritis","volume":"8","author":"Lai","year":"2019","journal-title":"Cells"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for cd40","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh443","article-title":"Down-regulation of cd40 and cd80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab","volume":"44","author":"Tokunaga","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (Anti-cd20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/art.10273","article-title":"The effect of anti-cd40 ligand antibody on B cells in human systemic lupus erythematosus","volume":"46","author":"Huang","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303239","article-title":"Engineering of a novel anti-cd40l domain antibody for treatment of autoimmune diseases","volume":"192","author":"Xie","year":"2014","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13075-015-0757-4","article-title":"Cdp7657, an anti-cd40l antibody lacking an fc domain, inhibits cd40l-dependent immune responses without thrombotic complications: an in vivo study","volume":"17","author":"Shock","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694356","article-title":"Persistence of long-lived plasma cells and humoral immunity in individuals responding to cd19-directed car T-cell therapy","volume":"128","author":"Bhoj","year":"2016","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.15218","article-title":"Fda approval of tisagenlecleucel: promise and complexities of a $475 000 cancer drug","volume":"318","author":"Bach","year":"2017","journal-title":"JAMA"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138416","article-title":"Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02231","article-title":"Chimeric antigen receptors based on low affinity mutants of fcepsilonri re-direct T cell specificity to cells expressing membrane ige","volume":"9","author":"Ward","year":"2018","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.3390\/cancers14205022","article-title":"Infectious complications of targeted therapies in children with leukemias and lymphomas","volume":"14","author":"Kyriakidis","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26309","article-title":"B cell depletion and sars-cov-2 vaccine responses in neuroimmunologic patients","volume":"91","author":"Kornek","year":"2022","journal-title":"Ann Neurol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077461","article-title":"Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response","volume":"67","author":"Oren","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211026272","article-title":"Increased rate of hospitalisation for covid-19 among rituximab-treated multiple sclerosis patients: A study of the swedish multiple sclerosis registry","volume":"28","author":"Spelman","year":"2022","journal-title":"Mult Scler"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11497","article-title":"Factors associated with serological response to sars-cov-2 vaccination in patients with multiple sclerosis treated with rituximab","volume":"5","author":"Tolf","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012249117","article-title":"B cells reappear less mature and more activated after their anti-cd20-mediated depletion in multiple sclerosis","volume":"117","author":"Nissimov","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00494","article-title":"Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy","volume":"4","author":"Mahevas","year":"2013","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in nzb\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200922","article-title":"Requirements of il-4 during the generation of B cell memory","volume":"210","author":"Chakma","year":"2023","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cell.2017.11.036","article-title":"Initiation of antiviral B cell immunity relies on innate signals from spatially positioned nkt cells","volume":"172","author":"Gaya","year":"2018","journal-title":"Cell"},{"key":"B148","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1038\/s41467-021-24090-z","article-title":"Influenza virus infection expands the breadth of antibody responses through il-4 signalling in B cells","volume":"12","author":"Miyauchi","year":"2021","journal-title":"Nat Commun"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.26.525749","article-title":"Il-4 downregulates bcl6 to promote memory B cell selection in germinal centers","author":"Shehata","year":"2023","journal-title":"bioRxiv"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/342385a0","article-title":"Induction of self-tolerance in mature peripheral B lymphocytes","volume":"342","author":"Goodnow","year":"1989","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.19.6149","article-title":"Increased expression of ia antigens on resting B cells: an additional role for B-cell growth factor","volume":"81","author":"Noelle","year":"1984","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.6.1459","article-title":"Human recombinant interleukin 4 induces fc epsilon receptors (Cd23) on normal human B lymphocytes","volume":"165","author":"DeFrance","year":"1987","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.8.3757","article-title":"The functional role of B cell antigen receptor stimulation and il-4 in the generation of human memory B cells from germinal center B cells","volume":"159","author":"Choe","year":"1997","journal-title":"J Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4049\/jimmunol.167.1.49","article-title":"The distinct roles of T cell-derived cytokines and a novel follicular dendritic cell-signaling molecule 8d6 in germinal center-B cell differentiation","volume":"167","author":"Zhang","year":"2001","journal-title":"J Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700141","article-title":"T follicular helper cell-derived il-4 is required for ige production during intestinal helminth infection","volume":"199","author":"Meli","year":"2017","journal-title":"J Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab080","article-title":"The role of il-4 derived from follicular helper T (Tfh) cells and type 2 helper T (Th2) cells","volume":"33","author":"Kubo","year":"2021","journal-title":"Int Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2147\/JAA.S287638","article-title":"Current perspectives on the systemic management of atopic dermatitis","volume":"14","author":"Davari","year":"2021","journal-title":"J Asthma Allergy"},{"key":"B158","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14862","article-title":"Dupilumab in adolescents with moderate to severe atopic dermatitis: A 32-week real-world experience during the covid-19 pandemic","volume":"47","author":"Hansel","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (Liberty ad chronos): A 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001279","article-title":"Recent advances in immunomodulators for atopic dermatitis","volume":"35","author":"Yim","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109130","article-title":"Il-4 receptor blockade is a global repressor of naive B cell development and responses in a dupilumab-treated patient","volume":"244","author":"Mountz","year":"2022","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1328785\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:00:34Z","timestamp":1707973234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1328785\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":163,"alternative-id":["10.3389\/fimmu.2024.1328785"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1328785","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"article-number":"1328785"}}